READ MORE:Pharmaceutical fat cats are already enjoying the blockbuster benefits of weight-loss drugs like Ozempic, with drug firms raking in a hefty £20billion from them this year.
Surveys suggest that the pet obesity crisis, much like the humans' own battle with the bulge, is getting worse. And of the vets asked 77 per cent said they believe the prevalence of obesity among pets has increased. Professor German added that although diet drugs for pets have been launched in the past, an oral drug called Slentrol, and failed to take off, he believed owners, and vets, were more likely to accept them in the Ozempic-era.
Better Choice is putting its money where its mouth is, planning to spend $1.5 million on trials for a pet-based GLP-1 agonist, the class of drugs Ozempic, Wegovy and Mounjaro belong to. Such a method he employs for dogs involves special food, exercise programmes depending on the breed and size of the pet, and methods to prolong eating such as puzzle feeders where the animal has to manually extracted food from a special bowl.
Advice for cats is a bit more broad, but the charity states our feline friends should still have plenty of opportunity for exercise such as climbing and playing every day.Weekly jabs like Ozempic, Wegovy and Mounjaro have proven to very effective in helping obese people shed excess pounds, with some people losing up to 22.5 per cent of their weight while on them.
Huge demand, including amongst those taking it for cosmetic reasons, has led to some diabetes patients running out.